Anybody else investing in SLS, DRTS and IBRX?

Original Reddit post

New investor describes holding SLS, DRTS and IBRX based on trial results, leadership and upcoming catalysts, with SLS possibly ending a trial early.

SLS — LONG The author is invested in SLS, citing great results, good leadership and multiple scheduled catalysts, including a possible early end to a trial that appears to be a huge success. The stated catalyst is the potential early trial termination announcement, which the author does not want to miss. The main risk is the author's own admission of being a new investor in a sector with a bad reputation.

in SLS- maybe an early end to a trial that seems to be a huge success

DRTS — LONG The author holds DRTS as one of three biotech picks, citing great results, good leadership and some approvals already in place. Multiple scheduled catalysts are the stated reason for holding and rotating capital between the names. The main risk is the author's inexperience and the sector's poor reputation.

these three stand out. Great results, good leadership and some approvals already

IBRX — LONG The author is invested in IBRX alongside SLS and DRTS, citing great results, good leadership and existing approvals. Scheduled catalysts are the reason for holding, with plans to move money as events occur. The main risk is the author's newness and the sector's reputation.

I'm investing in all three. Planning to move the money around as different catalysts come